Paper · 31820522
Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
Zhou J and 4 others. Cell Prolif, 2020. Cited by 256 papers, by iCite. Retracted.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. Papers, record 31820522. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31820522
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Abietanes | Major topic |
| Apoptosis | Major topic |
| Autophagy | Major topic |
| Ovarian Neoplasms | Major topic |
| Phosphatidylinositol 3-Kinases | Major topic |
| Proto-Oncogene Proteins c-akt | Major topic |
| TOR Serine-Threonine Kinases | Major topic |
| Animals | |
| Antineoplastic Agents, Phytogenic | |
| Caspase 3 | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Cell Survival | |
| Female | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Signal Transduction | |
| Xenograft Model Antitumor Assays |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2019YFS0021 | Sichuan Science and Technology Program | PubMed | ||
| 2018TJPT0013 | Sichuan Science and Technology Program | PubMed | ||
| 2016NYZ0036 | Sichuan Crops and Animals Breeding Special Project | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Retracted by | 39,443,824 | RETRACTION: Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway. | https://conductscience.org/library/papers/39443824 |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,333,502 | Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. | Pharmacol Ther | 2014 | https://conductscience.org/library/papers/24333502 | PubMed |
| 2 | 19,001,436 | Anticancer effects of tanshinone I in human non-small cell lung cancer. | Mol Cancer Ther | 2008 | https://conductscience.org/library/papers/19001436 | PubMed |
| 3 | 26,283,590 | Blockade of TNF-α-induced NF-κB signaling pathway and anti-cancer therapeutic response of dihydrotanshinone I. | Int Immunopharmacol | 2015 | https://conductscience.org/library/papers/26283590 | PubMed |
| 4 | 26,583,091 | PI3K/AKT/mTOR/p70S6K Pathway Is Involved in Aβ25-35-Induced Autophagy. | Biomed Res Int | 2015 | https://conductscience.org/library/papers/26583091 | PubMed |
| 5 | 28,306,502 | Pacer Mediates the Function of Class III PI3K and HOPS Complexes in Autophagosome Maturation by Engaging Stx17. | Mol Cell | 2017 | https://conductscience.org/library/papers/28306502 | PubMed |
| 6 | 16,955,220 | Growth inhibition and induction of apoptosis and differentiation of tanshinone IIA in human glioma cells. | J Neurooncol | 2007 | https://conductscience.org/library/papers/16955220 | PubMed |
| 7 | 25,619,832 | Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. | Oncogene | 2015 | https://conductscience.org/library/papers/25619832 | PubMed |
| 8 | 25,482,988 | PLC and PI3K/Akt/mTOR signalling in disease and cancer. | Adv Biol Regul | 2015 | https://conductscience.org/library/papers/25482988 | PubMed |
| 9 | 29,891,531 | Autophagy in cancer: a complex relationship. | Biochem J | 2018 | https://conductscience.org/library/papers/29891531 | PubMed |
| 10 | 25,257,169 | Autosis and autophagic cell death: the dark side of autophagy. | Cell Death Differ | 2015 | https://conductscience.org/library/papers/25257169 | PubMed |
1 to 10 of 55
See all 55 referencesCited by165
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 256 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,979,277 | Role of PI3K/Akt/mTOR signaling in the therapeutic effects of Fuzheng Lishi Huayu Decoction on persistent Chlamydia trachomatis infection. | J Tradit Complement Med | 2026 | https://conductscience.org/library/papers/42979277 | PubMed |
| 42,656,404 | Targeting RSF1 with tanshinone I inhibits cervical cancer cell growth through modulation of NF-κB pathway. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42656404 | PubMed |
| 42,298,679 | A review of PI3K/AKT/mTOR inhibitors from traditional Chinese medicine: potential and perspective for activated phosphoinositide 3-kinase δ syndrome. | Orphanet J Rare Dis | 2026 | https://conductscience.org/library/papers/42298679 | PubMed |
| 42,224,092 | WDR72 Drives Esophageal Squamous Cell Carcinoma Progression by Inhibiting Autophagy via the PI3K/Akt/mTOR Pathway. | Kaohsiung J Med Sci | 2026 | https://conductscience.org/library/papers/42224092 | PubMed |
| 42,095,894 | SETDB1 induces H3K9me3 methylation modification of RASSF2 to inhibit PTEN and facilitate ovarian cancer progression. | Mol Genet Genomics | 2026 | https://conductscience.org/library/papers/42095894 | PubMed |
| 41,929,250 | Therapeutic functions of tanshinone IIA in a zebrafish model of glucocorticoid-induced osteoporosis. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/41929250 | PubMed |
| 41,852,887 | Apoptotic body-encapsulated zinc-doped Salvia miltiorrhiza carbon dots trigger PANoptosis for targeted therapy of hepatocellular carcinoma. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/41852887 | PubMed |
| 41,571,749 | Upregulated miR-204-5p inhibits oral squamous cell carcinoma progression via inducing autophagy-promoted apoptosis by targeting PIK3CB. | Sci Rep | 2026 | https://conductscience.org/library/papers/41571749 | PubMed |
| 41,511,607 | Tanshinone I Promotes Ferroptosis of Cervical Cancer Cells by Activating the ATF3-Mediated Transcriptional Inhibition of FSP1. | Appl Biochem Biotechnol | 2026 | https://conductscience.org/library/papers/41511607 | PubMed |
| 41,399,788 | Salvia miltiorrhiza water extract ameliorated cGAS-STING-mediated acute liver injury by blocking interaction between STING and TBK1. | Chin Herb Med | 2025 | https://conductscience.org/library/papers/41399788 | PubMed |
1 to 10 of 165
See all 165 cited byGenes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| ATG7 | 10,533 | PubTator's text mining | https://conductscience.org/library/genes/10533 | NCBI Gene |
| BECN1 | 8,678 | PubTator's text mining | https://conductscience.org/library/genes/8678 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| H3P16 | 644,914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| MAP1LC3A | 84,557 | PubTator's text mining | https://conductscience.org/library/genes/84557 | NCBI Gene |
| MTOR | 2,475 | PubTator's text mining | https://conductscience.org/library/genes/2475 | NCBI Gene |
| NUP62 | 23,636 | PubTator's text mining | https://conductscience.org/library/genes/23636 | NCBI Gene |
| STAT3 | 6,774 | PubTator's text mining | https://conductscience.org/library/genes/6774 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31820522
GET https://conductscience.org/api/papers/v1/31820522/references?page=2